H1 2024 Life Sciences Update Market Summaries

Germany: Berlin

View H1 2024 Life Sciences Update

View All Markets

Market Summary

Public & Private Funding (2024 H1)

Fast Lab Stats

• The Berlin investment market reached a volume of 1.91 billion euros in the first half of 2024, 49% below the past five-year-average for the same period. The investment market is characterized by insolvencies, which are set to be the main driver of transactions for 2024. A stabilization in yields can be observed. • While there is liquidity in the life sciences sector, quality product is scarce. Due to the hike in construction costs in recent years, many developers are currently reluctant to sell. Tenant demand for quality lab space in Berlin is driven by a range of life sciences companies and institutes, from small to large, both national and international. At the same time, public institutions and organizations primarily aim to keep ownership of their build-to-suit properties. • Berlin’s life sciences sector benefits from a strong research and hospital landscape and a close link between business and politics. The areas of biotechnology, pharmaceutical and medical technology are particularly pronounced. • Germany’s capital has a high density of scientific institutions and life sciences institutions, including the Charité University Hospital, various Robert Koch Institutes and Helmholtz Institutes. • Berlin also has a large talent pool, with over 200 degree-programs in the field of health and life sciences offered from about 30 universities and colleges, including Humboldt University, TU Berlin and Freie Universität Berlin.

€ Raised (MM)

Company

Deal Type

Completed

Type

34.2K Total Life Sciences Employment 640 Life Science Companies > 40 Research facilities/ institutes

Tacalyx

Seed Round

Jun 2024

2nd Round

€ 15.2

Sanity Group

Later Stage VC

Jun 2024

7th Round

€ 15.1

Captain T Cell

Seed Round

May 2024

1st Round

€ 9.2

Pacifico Biolabs

Seed Round

Feb 2024

2nd Round

€ 3.3

Cellbricks

Later Stage VC

Apr 2024

2nd Round

DiaMonTech

Accelerator/Incubator

Jan 2024

Mika (Clinics/Outpatient Services)

Accelerator/Incubator

Feb 2024

Reactosome

Seed Round

Jun 2024

1st Round

Representative Investment Sale Transactions (Q3 2022 – Q2 2024)

Address

Type

Volume (€m)

GLA (sqm)

Date

Buyer

Scienion, Wagner-Regeny-Strasse 15

Lab/Office

c. 21

5,200

Q3 2023 BEOS AG

Max-Planck-Strasse 2 Am Mühlenberg 9

R&D/Office Lab / Office

c. 10 c. 95

3,100

Q4 2022 Fidelity International

18,900

Q3 2022 GARBE IM

Representative Life Sciences Companies

Life Sciences Labor: Annual Chemist Job Postings

1,200

Company

Type

Representative Lease Transactions (Q3 2022 – Q2 2024)

1,000

Berlin Chemie

Pharma

Company

Address

GLA (sqm) New/Renewal

Type

Quarter

Landlord

800

Bayer Pharma

Pharma

Pfizer Germany

Friedrichstraße 110-111

5,900 New Letting

Office Q3 2022 Parella Weinberg

600

Aurora Europe

An den Ceciliengarten, Hauptstrasse

1,300 New letting

Office Q1 2023 Panthier Real Esztate

Pfizer

Biotechnology, Pharma

JPT Peptide Tech

Karl-Ziegler Strasse

1,500 New occupation Office Q1 2023 Owner occupier

400

Penumbra Europe

Ullsteinhaus, Mariendorfer Damm

1,000 New letting

Office Q1 2023 Samwer family

Sanofi

Pharma

200

Janssen-Cilag

Potsdamer Platz 11

800 New letting

Office Q4 2022 Brookfield Properties

-

B. Braun Melsungen

Pharma

Hologic Deutschland Kaiserin-Augusta-Allee 112-113

1,000 New letting

Office Q4 2022 Deutsche Investment

2019

2020

2021

2022

BioNTech

Voltairestraße 8

1,400 New letting

Office Q3 2022 ABG

Bio Degree-Awarding Institutions, Metro Area • Humboldt-Universität Berlin • Freie Universität Berlin • Charité – Universitätsmedizin Berlin

Cheplapharm Arzneimittel

Friedrichstraße 140

830 New letting

Office Q1 2024 Müller-Spreer AG

Contributors Benedikt Kiefer benedikt.kiefer@cushwake.com

Simon Jeschioro simon.jeschioro@cushwake.com

Sources: Cushman & Wakefield Research, CoStar, National Institutes of Health (NIH), Lightcast, Pitchbook, Federal Reserve Economic Data (FRED)

CUSHMAN & WAKEFIELD

LIFE SCIENCES UPDATE | 2024 SEPTEMBER